PRIDINOL MONOMESYLATE
Spondyloarthropathy
University of PalermoSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Spondyloarthropathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tucidinostat University of Palermo | N/A | D |
cc-5013 University of Palermo | N/A | D |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →